论文部分内容阅读
目的探讨分析对肝癌患者肝动脉化疗栓塞(TACE)联合射频消融(RFA)治疗的近期疗效及其对肿瘤局部复发的影响。方法 90例肝癌患者,将其随机分为TACE联合RFA组(联合组)、单纯TACE组和单纯RFA组,各30例。对比分析三组患者近期疗效和肿瘤局部复发率。结果经治疗,联合组与单纯TACE组、单纯RFA组疗效对比差异有统计学意义(P<0.05)。联合组有3例肿瘤局部复发,占10.00%,单纯TACE组有5例,占16.67%,单纯RFA组有5例,占16.67%,三组比较差异无统计学意义(P>0.05)。结论运用TACE联合RFA治疗肝癌效果显著,能降低肿瘤复发风险,延长患者生存期,值得临床推广和应用。
Objective To investigate the short-term effect of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in patients with liver cancer and its effect on the local recurrence of tumor. Methods Totally 90 HCC patients were randomly divided into TACE group and RFA group (combination group), TACE group and RFA group (30 cases each). Comparative analysis of three groups of patients with short-term efficacy and local tumor recurrence rate. Results After treatment, there was significant difference in curative effect between the combination group and the simple TACE group and the simple RFA group (P <0.05). There were 3 tumor recurrences in the combined group (10.00%), 5 cases (16.67%) in the TACE alone group and 5 (16.67%) in the RFA group. There was no significant difference between the three groups (P> 0.05). Conclusion The combination of TACE and RFA has a significant effect on the treatment of liver cancer, which can reduce the risk of tumor recurrence and prolong the survival of patients. It is worthy of clinical promotion and application.